Medisus Pharma

Azel 40mg Capsule is a prescription medication containing enzalutamide, an anti-cancer drug used in adult men for the treatment of various stages of prostate cancer. It works as an androgen receptor inhibitor to slow the growth of cancer cells by blocking the effects of male hormones like testosterone. 

The GLENZA 160 tablet is a prescription anti-cancer medication containing enzalutamide (160 mg) as its active ingredient. It is primarily used to treat advanced prostate cancer in adult men by blocking the effects of male hormones that fuel cancer cell growth. 

The Samluta 40mg capsule is a prescription medication containing the active ingredient Enzalutamide, which is primarily used to treat various stages of prostate cancer in men. It is an anti-cancer drug classified as an androgen receptor inhibitor. 

Enzamide 80 mg capsule is a prescription anti-cancer medication containing enzalutamide, which is an androgen receptor inhibitor. It is primarily used to treat various stages of prostate cancer in men by blocking the effects of male hormones (androgens) like testosterone that fuel cancer cell growth. 

Glenza 40mg Capsule is a prescription medication containing Enzalutamide, an anti-cancer drug used primarily to treat advanced prostate cancer in men. It works by blocking the effects of male hormones (androgens) like testosterone, which promotes the growth of prostate cancer cells. 

MAKENZA 40 (Megahenz 40) is a medication containing Megestrol, a synthetic progesterone used primarily for hormone-dependent cancers like breast and endometrial cancer, working by interfering with hormones that fuel cancer growth, and also for managing weight loss/poor appetite in advanced cancer/AIDS by increasing appetite and causing weight gain, but it requires doctor supervision due to side effects like hot flashes, weight changes, and potential blood sugar/liver issues. 

The Azel 160 tablet is a prescription medication containing Enzalutamide (160 mg), primarily used to treat advanced prostate cancer in men. It belongs to a class of drugs known as androgen receptor inhibitors. 

The medication referred to as SAMLUTA 160 is likely a 160 mg dose of the drug enzalutamide, an androgen receptor inhibitor used to treat prostate cancer. The standard daily dosage is typically 160 mg, often achieved by taking four 40 mg capsules. 

MAKENZA 160 is a prescription medicine containing Enzalutamide, primarily used to treat prostate cancer in men. It is an anti-cancer agent that belongs to a class of drugs known as androgen receptor inhibitors. 

Enzana 80 mg is a prescription oral capsule containing Enzalutamide, an anti-androgen medication used to treat various forms of prostate cancer (metastatic, non-metastatic castration-resistant, and hormone-sensitive) by blocking testosterone's effects on cancer cells, slowing growth, and potentially shrinking tumors. It's for men only, taken daily, and common side effects include fatigue, hot flashes, weakness, high blood pressure, and decreased appetite, requiring caution with sun exposure and effective contraception. 

Obnyx 40mg capsule contains the active ingredient Enzalutamide. It is an antineoplastic drug that belongs to the category of medicines known as androgen receptor inhibitors. This medication is used in the treatment of advanced prostate cancer in patients who do not respond to surgical or hormonal treatments.